GFAP and neuromyelitis optica: We observed complement-dependent astrocyte pathology at the needle insertion site induced by intrathecally delivered NMO-IgG and complement, identified as loss of staining for the astrocytic markers AQP4 and GFAP together with deposition of IgG and activated complement.